Daiwa Securities Group Inc. - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 111 filers reported holding REVANCE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.67 and the average weighting 0.7%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4
-50.0%
3310.0%0.00%
Q2 2023$8
-27.3%
3310.0%0.00%
Q1 2023$11
+83.3%
3310.0%0.00%
Q4 2022$6
-99.9%
331
+34.6%
0.00%
Q3 2022$7,000
+133.3%
2460.0%0.00%
Q2 2022$3,000
-40.0%
2460.0%0.00%
Q1 2022$5,000
+25.0%
2460.0%0.00%
Q4 2021$4,000
-42.9%
2460.0%0.00%
Q3 2021$7,000
+75.0%
246
+74.5%
0.00%
Q2 2021$4,0000.0%1410.0%0.00%
Q1 2021$4,0000.0%141
+12.8%
0.00%
Q4 2020$4,000
-50.0%
125
-60.6%
0.00%
Q3 2020$8,000
+60.0%
3170.0%0.00%
Q2 2020$5,0000.0%3170.0%0.00%
Q1 2020$5,0000.0%317
+13.2%
0.00%
Q4 2019$5,000
+25.0%
2800.0%0.00%
Q3 2019$4,0000.0%2800.0%0.00%
Q2 2019$4,0000.0%2800.0%0.00%
Q1 2019$4,0000.0%280
+38.6%
0.00%
Q4 2018$4,000
-20.0%
2020.0%0.00%
Q3 2018$5,000
-16.7%
2020.0%0.00%
Q2 2018$6,0000.0%2020.0%0.00%
Q1 2018$6,0002020.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$42,779,00061.17%
Essex Woodlands Management, Inc. 3,342,047$91,739,00021.30%
Sio Capital Management, LLC 101,292$2,780,0001.54%
Fosun International Ltd 472,532$12,971,0000.66%
Rhenman & Partners Asset Management AB 203,181$5,577,0000.57%
ArrowMark Colorado Holdings LLC 1,804,275$49,527,0000.46%
ESSEX INVESTMENT MANAGEMENT CO LLC 87,355$2,398,0000.30%
FOX RUN MANAGEMENT, L.L.C. 18,477$507,0000.16%
Phoenix Investment Adviser LLC 2,400$66,0000.12%
Quinn Opportunity Partners LLC 33,100$909,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders